Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 52 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/11/24
End: 07/31/26
Due: 07/31/27
Phase: N/A
Priority: Normal
Start: 03/15/24
End: 09/15/25
Due: 09/15/26
Phase: N/A
Priority: Normal
Start: 08/01/19
End: 02/28/21
Due: 02/28/22
Phase: N/A
Priority: Normal
Start: 09/22/20
End: 01/01/24
Due: 01/01/25
Phase: N/A
Priority: Normal
Start: 01/15/15
End: 01/15/18
Due: 01/15/19
Phase: N/A
Priority: Normal
Start: 07/31/08
End: 06/30/10
Due: 06/30/11
Phase: N/A
Priority: Normal
Start: 03/15/17
End: 12/15/20
Due: 12/15/21
Phase: N/A
Priority: Normal
Start: 12/15/17
End: 06/15/19
Due: 06/15/20
Phase: N/A
Priority: Normal
Start: 03/15/17
End: 12/15/20
Due: 12/15/21
Phase: N/A
Priority: Normal
Start: 05/31/12
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 04/01/19
End: 04/30/22
Due: 04/30/23
Phase: N/A
Priority: Normal
Start: 06/01/23
End: 06/01/25
Due: 06/01/26
Phase: N/A
Priority: Normal
Start: 01/01/23
End: 11/01/24
Due: 11/01/25
Phase: N/A
Priority: Normal
Start: 08/31/18
End: 12/15/20
Due: 12/15/21
Phase: N/A
Priority: Normal
Start: 05/06/20
End: 05/15/24
Due: 05/15/25
Phase: N/A
Priority: Normal
Start: 07/15/22
End: 12/30/22
Due: 12/30/23
Phase: N/A
Priority: Normal
Start: 01/14/20
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 11/01/21
End: 02/28/25
Due: 02/28/26
Phase: N/A
Priority: Normal
Start: 05/10/23
End: 05/31/26
Due: 05/31/27
Phase: N/A
Priority: Normal
Start: 12/20/23
End: 05/20/25
Due: 05/20/26
Phase: N/A
Priority: Normal
Start: 06/30/21
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 02/01/19
End: 09/30/22
Due: 09/30/23
Phase: N/A
Priority: Normal
Start: 07/01/24
End: 12/01/25
Due: 12/01/26
Phase: N/A
Priority: Normal
Start: 11/30/13
End: 02/29/16
Due: 02/28/17
Neurophysiological, Biomolecular and Psychological Aspects of Erenumab Treatment in Chronic Migraine
Phase: N/A
Priority: Normal
Start: 01/15/20
End: 06/30/21
Due: 06/30/22